$0.17
▲ +7.1% Today
as of Oct 22, 16:52 ET
Last 30 days
Recent Press Releases & News
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Silexion Therapeutics Announces Exercise of Warrants
Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers
SLXN earnings at a glance
The share price of $0.17 sits near its 52-week low.
Overview
52-week range
$0.14
$36
0% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $5.17 | — | — | — | — | financials |
| Wed Nov 12, 2025 | Sep/2025 | $-2.88 | — | — | — | — | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-4.32 | — | — | — | — | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $274.25 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $197.80 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $12.29 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.78 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $6.54 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-3M | $-2M | $-8M | $-1M | $-1M | $-731,000 |
| Net income | $-4M | — | $-3M | $-3M | $-12M | $-1M | $-1M | $-809,000 |
| EPS (diluted) | $5.17 | — | $2.88 | $43.19 | $274.25 | $197.80 | $12.29 | $0.78 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2M | $6M | $9M | $3M | $2M | $2M | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $4M | $7M | $11M | $5M | $3M | $2M | — | — |
| Total assets | $4M | $7M | $12M | $6M | $3M | $2M | $4M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $4M | $5M | $5M | $6M | $8M | $2M | — | — |
| Total equity | $44,000 | $3M | $7M | $120,000 | $-5M | $153,000 | $2M | $-5M |
Implied volatility — last 90 days
No IV snapshots yet for SLXN.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.